
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Immune Checkpoint Inhibition in Sepsis: A Phase 1b Randomized, Placebo-Controlled, Single Ascending Dose Study of Antiprogrammed Cell Death-Ligand 1 Antibody (BMS-936559)*
Richard S. Hotchkiss, Elizabeth Colston, Sachin Yende, et al.
Critical Care Medicine (2019) Vol. 47, Iss. 5, pp. 632-642
Open Access | Times Cited: 192
Richard S. Hotchkiss, Elizabeth Colston, Sachin Yende, et al.
Critical Care Medicine (2019) Vol. 47, Iss. 5, pp. 632-642
Open Access | Times Cited: 192
Showing 1-25 of 192 citing articles:
Cytokine Storm in COVID-19: The Current Evidence and Treatment Strategies
Yujun Tang, Jiajia Liu, Dingyi Zhang, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 1032
Yujun Tang, Jiajia Liu, Dingyi Zhang, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 1032
The immunology of sepsis
Tom van der Poll, Manu Shankar‐Hari, W. Joost Wiersinga
Immunity (2021) Vol. 54, Iss. 11, pp. 2450-2464
Open Access | Times Cited: 537
Tom van der Poll, Manu Shankar‐Hari, W. Joost Wiersinga
Immunity (2021) Vol. 54, Iss. 11, pp. 2450-2464
Open Access | Times Cited: 537
The foundations of immune checkpoint blockade and the ipilimumab approval decennial
Alan J. Korman, Sarah C. Garrett-Thomson, Nils Lönberg
Nature Reviews Drug Discovery (2021) Vol. 21, Iss. 7, pp. 509-528
Closed Access | Times Cited: 373
Alan J. Korman, Sarah C. Garrett-Thomson, Nils Lönberg
Nature Reviews Drug Discovery (2021) Vol. 21, Iss. 7, pp. 509-528
Closed Access | Times Cited: 373
Sepsis therapies: learning from 30 years of failure of translational research to propose new leads
Jean‐Marc Cavaillon, Mervyn Singer, Tomasz Skirecki
EMBO Molecular Medicine (2020) Vol. 12, Iss. 4
Open Access | Times Cited: 232
Jean‐Marc Cavaillon, Mervyn Singer, Tomasz Skirecki
EMBO Molecular Medicine (2020) Vol. 12, Iss. 4
Open Access | Times Cited: 232
Sepsis-Induced Immunosuppression
Lisa K. Torres, Peter Pickkers, Tom van der Poll
Annual Review of Physiology (2021) Vol. 84, Iss. 1, pp. 157-181
Open Access | Times Cited: 207
Lisa K. Torres, Peter Pickkers, Tom van der Poll
Annual Review of Physiology (2021) Vol. 84, Iss. 1, pp. 157-181
Open Access | Times Cited: 207
The roles of macrophage polarization in the host immune response to sepsis
Xin-sen Chen, Yancun Liu, Yulei Gao, et al.
International Immunopharmacology (2021) Vol. 96, pp. 107791-107791
Closed Access | Times Cited: 173
Xin-sen Chen, Yancun Liu, Yulei Gao, et al.
International Immunopharmacology (2021) Vol. 96, pp. 107791-107791
Closed Access | Times Cited: 173
Systemic Inflammatory Response Syndrome After Surgery: Mechanisms and Protection
Andreas Margraf, Nadine Ludwig, Alexander Zarbock, et al.
Anesthesia & Analgesia (2020) Vol. 131, Iss. 6, pp. 1693-1707
Closed Access | Times Cited: 163
Andreas Margraf, Nadine Ludwig, Alexander Zarbock, et al.
Anesthesia & Analgesia (2020) Vol. 131, Iss. 6, pp. 1693-1707
Closed Access | Times Cited: 163
Immune checkpoint inhibition in sepsis: a Phase 1b randomized study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of nivolumab
Richard S. Hotchkiss, Elizabeth Colston, Sachin Yende, et al.
Intensive Care Medicine (2019) Vol. 45, Iss. 10, pp. 1360-1371
Open Access | Times Cited: 149
Richard S. Hotchkiss, Elizabeth Colston, Sachin Yende, et al.
Intensive Care Medicine (2019) Vol. 45, Iss. 10, pp. 1360-1371
Open Access | Times Cited: 149
Neutrophils in acute inflammation: current concepts and translational implications
Andreas Margraf, Clifford A. Lowell, Alexander Zarbock
Blood (2021) Vol. 139, Iss. 14, pp. 2130-2144
Open Access | Times Cited: 104
Andreas Margraf, Clifford A. Lowell, Alexander Zarbock
Blood (2021) Vol. 139, Iss. 14, pp. 2130-2144
Open Access | Times Cited: 104
The pathophysiology of sepsis and precision-medicine-based immunotherapy
Evangelos J. Giamarellos‐Bourboulis, Anna C. Aschenbrenner, Michael Bauer, et al.
Nature Immunology (2024) Vol. 25, Iss. 1, pp. 19-28
Closed Access | Times Cited: 93
Evangelos J. Giamarellos‐Bourboulis, Anna C. Aschenbrenner, Michael Bauer, et al.
Nature Immunology (2024) Vol. 25, Iss. 1, pp. 19-28
Closed Access | Times Cited: 93
The Pathophysiology of Sepsis-Associated AKI
Shuhei Kuwabara, Eibhlin Goggins, Mark D. Okusa
Clinical Journal of the American Society of Nephrology (2022) Vol. 17, Iss. 7, pp. 1050-1069
Open Access | Times Cited: 92
Shuhei Kuwabara, Eibhlin Goggins, Mark D. Okusa
Clinical Journal of the American Society of Nephrology (2022) Vol. 17, Iss. 7, pp. 1050-1069
Open Access | Times Cited: 92
Immune dysregulation in sepsis: experiences, lessons and perspectives
Min Cao, Guozheng Wang, Jianfeng Xie
Cell Death Discovery (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 60
Min Cao, Guozheng Wang, Jianfeng Xie
Cell Death Discovery (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 60
Profiling the dysregulated immune response in sepsis: overcoming challenges to achieve the goal of precision medicine
Sara Cajander, Matthijs Kox, Brendon P. Scicluna, et al.
The Lancet Respiratory Medicine (2023) Vol. 12, Iss. 4, pp. 305-322
Open Access | Times Cited: 50
Sara Cajander, Matthijs Kox, Brendon P. Scicluna, et al.
The Lancet Respiratory Medicine (2023) Vol. 12, Iss. 4, pp. 305-322
Open Access | Times Cited: 50
Infectious Complications of Biological and Small Molecule Targeted Immunomodulatory Therapies
Joshua S. Davis, David Ferreira, Emma Paige, et al.
Clinical Microbiology Reviews (2020) Vol. 33, Iss. 3
Open Access | Times Cited: 115
Joshua S. Davis, David Ferreira, Emma Paige, et al.
Clinical Microbiology Reviews (2020) Vol. 33, Iss. 3
Open Access | Times Cited: 115
Multicentric experience with interferon gamma therapy in sepsis induced immunosuppression. A case series
Didier Payen, Valérie Faivre, Jordi Miatello, et al.
BMC Infectious Diseases (2019) Vol. 19, Iss. 1
Open Access | Times Cited: 108
Didier Payen, Valérie Faivre, Jordi Miatello, et al.
BMC Infectious Diseases (2019) Vol. 19, Iss. 1
Open Access | Times Cited: 108
Immunotherapy in sepsis - brake or accelerate?
Folkert Steinhagen, Susanne V. Schmidt, Jens‐Christian Schewe, et al.
Pharmacology & Therapeutics (2020) Vol. 208, pp. 107476-107476
Open Access | Times Cited: 108
Folkert Steinhagen, Susanne V. Schmidt, Jens‐Christian Schewe, et al.
Pharmacology & Therapeutics (2020) Vol. 208, pp. 107476-107476
Open Access | Times Cited: 108
Immune Deregulation in Sepsis and Septic Shock: Reversing Immune Paralysis by Targeting PD-1/PD-L1 Pathway
Yuki Nakamori, Eun Jeong Park, Motomu Shimaoka
Frontiers in Immunology (2021) Vol. 11
Open Access | Times Cited: 100
Yuki Nakamori, Eun Jeong Park, Motomu Shimaoka
Frontiers in Immunology (2021) Vol. 11
Open Access | Times Cited: 100
Monocytic HLA-DR expression kinetics in septic shock patients with different pathogens, sites of infection and adverse outcomes
Guus P. Leijte, Thomas Rimmelé, Matthijs Kox, et al.
Critical Care (2020) Vol. 24, Iss. 1
Open Access | Times Cited: 94
Guus P. Leijte, Thomas Rimmelé, Matthijs Kox, et al.
Critical Care (2020) Vol. 24, Iss. 1
Open Access | Times Cited: 94
Myeloid-derived suppressor cell function and epigenetic expression evolves over time after surgical sepsis
McKenzie K. Hollen, Julie A. Stortz, Dijoia B. Darden, et al.
Critical Care (2019) Vol. 23, Iss. 1
Open Access | Times Cited: 88
McKenzie K. Hollen, Julie A. Stortz, Dijoia B. Darden, et al.
Critical Care (2019) Vol. 23, Iss. 1
Open Access | Times Cited: 88
The Critical Roles and Mechanisms of Immune Cell Death in Sepsis
Zhenxing Cheng, Simon T. Abrams, Julien Toh, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 79
Zhenxing Cheng, Simon T. Abrams, Julien Toh, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 79
Role of the adaptive immune response in sepsis
Jack Brady, Shahd Horie, John G. Laffey
Intensive Care Medicine Experimental (2020) Vol. 8, Iss. S1
Open Access | Times Cited: 79
Jack Brady, Shahd Horie, John G. Laffey
Intensive Care Medicine Experimental (2020) Vol. 8, Iss. S1
Open Access | Times Cited: 79
Cancer Management during COVID-19 Pandemic: Is Immune Checkpoint Inhibitors-Based Immunotherapy Harmful or Beneficial?
Silvia Vivarelli, Luca Falzone, Caterina Grillo, et al.
Cancers (2020) Vol. 12, Iss. 8, pp. 2237-2237
Open Access | Times Cited: 78
Silvia Vivarelli, Luca Falzone, Caterina Grillo, et al.
Cancers (2020) Vol. 12, Iss. 8, pp. 2237-2237
Open Access | Times Cited: 78
Respiratory viral sepsis: epidemiology, pathophysiology, diagnosis and treatment
Xiaoying Gu, Fei Zhou, Yeming Wang, et al.
European Respiratory Review (2020) Vol. 29, Iss. 157, pp. 200038-200038
Open Access | Times Cited: 77
Xiaoying Gu, Fei Zhou, Yeming Wang, et al.
European Respiratory Review (2020) Vol. 29, Iss. 157, pp. 200038-200038
Open Access | Times Cited: 77
The multifactorial mechanisms of bacterial infection in decompensated cirrhosis
Van der Merwe, Shilpa Chokshi, Christine Bernsmeier, et al.
Journal of Hepatology (2021) Vol. 75, pp. S82-S100
Closed Access | Times Cited: 65
Van der Merwe, Shilpa Chokshi, Christine Bernsmeier, et al.
Journal of Hepatology (2021) Vol. 75, pp. S82-S100
Closed Access | Times Cited: 65
Targeting Neutrophils in Sepsis: From Mechanism to Translation
Xiaofei Shen, Ke Cao, Yang Zhao, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 59
Xiaofei Shen, Ke Cao, Yang Zhao, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 59